{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:13:03Z","timestamp":1761743583948,"version":"build-2065373602"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the association of pre\u2010 and post\u2010diagnosis fluid intake with non\u2010muscle\u2010invasive bladder cancer (NMIBC) recurrence and progression risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      Data were used from the multicentre prospective cohort study UroLife. Participants reported pre\u2010diagnosis fluid intake at 6\u2009weeks (food frequency questionnaire [FFQ]) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091322) and post\u2010diagnosis fluid intake at 3 and 15\u2009months (FFQ and 4\u2010day 24\u2010h fluid diaries) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091275) after diagnosis. Multivariable proportional hazard regression models were used to obtain hazard ratios (HRs) and 95% confidence intervals (CIs) for the association of fluid intake with risk of first and multiple recurrence(s) and progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median overall follow\u2010up of 4.6\u2009years, 474 patients had one or more recurrence and 142 had progression. A higher first recurrence risk was observed for patients with the highest pre\u2010diagnosis fluid intakes (\u22652300 vs 1500\u20131900\u2009mL\/day: HR 1.38, 95% CI 1.07\u20131.79), but not for those with the highest post\u2010diagnosis fluid intakes. HRs were similar for multiple recurrence risk. For progression, each 150\u2009mL\/day increase in both pre\u2010 and post\u2010diagnosis fluid intake was consistently associated with an increased risk (post\u2010diagnosis [3\u2009months] FFQ\u2010based: HR 1.05, 95% CI 1.01\u20131.09 and diary\u2010based: HR 1.04, 95% CI 0.99\u20131.09).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High fluid intakes may be associated with higher NMIBC recurrence and especially progression risk. These findings lack a clear explanation but may be related to extensive expansion of the bladder wall or urinary symptoms. Further research is warranted. Meanwhile, these findings do not support recommending high(er) fluid intakes to patients with NMIBC to decrease their recurrence or progression risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.16665","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T06:40:47Z","timestamp":1737787247000},"page":"429-438","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluid intake and recurrence and progression risk of patients with non\u2010muscle\u2010invasive bladder cancer"],"prefix":"10.1111","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8424-7638","authenticated-orcid":false,"given":"Ivy","family":"Beeren","sequence":"first","affiliation":[{"name":"IQ Health science department Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Meijer","sequence":"additional","affiliation":[{"name":"IQ Health science department Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-8601","authenticated-orcid":false,"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[{"name":"Department of Urology Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-2147","authenticated-orcid":false,"given":"Katja K.H.","family":"Aben","sequence":"additional","affiliation":[{"name":"IQ Health science department Radboud University Medical Center  Nijmegen The Netherlands"},{"name":"Department of Research and Development Netherlands Comprehensive Cancer Organization  Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[{"name":"Department of Urology Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-1326","authenticated-orcid":false,"given":"Lambertus A.L.M.","family":"Kiemeney","sequence":"additional","affiliation":[{"name":"IQ Health science department Radboud University Medical Center  Nijmegen The Netherlands"},{"name":"Department of Urology Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-2125","authenticated-orcid":false,"given":"Alina","family":"Vrieling","sequence":"additional","affiliation":[{"name":"IQ Health science department Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_10_2_1","DOI":"10.1038\/s41571-023-00744-3"},{"doi-asserted-by":"publisher","key":"e_1_2_10_3_1","DOI":"10.1016\/j.eururo.2021.08.010"},{"doi-asserted-by":"publisher","key":"e_1_2_10_4_1","DOI":"10.18632\/oncotarget.18100"},{"doi-asserted-by":"publisher","key":"e_1_2_10_5_1","DOI":"10.1080\/01635581.2018.1512636"},{"key":"e_1_2_10_6_1","first-page":"437","article-title":"Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer","volume":"78","author":"Braver DJ","year":"1987","journal-title":"J Natl Cancer Inst"},{"doi-asserted-by":"publisher","key":"e_1_2_10_7_1","DOI":"10.1159\/000280070"},{"doi-asserted-by":"publisher","key":"e_1_2_10_8_1","DOI":"10.1152\/ajprenal.00282.2013"},{"doi-asserted-by":"publisher","key":"e_1_2_10_9_1","DOI":"10.1186\/1476-069X-13-44"},{"doi-asserted-by":"publisher","key":"e_1_2_10_10_1","DOI":"10.1097\/01.ju.0000091803.35049.da"},{"doi-asserted-by":"publisher","key":"e_1_2_10_11_1","DOI":"10.3233\/BLC-180172"},{"doi-asserted-by":"publisher","key":"e_1_2_10_12_1","DOI":"10.1136\/bmjopen-2019-030396"},{"doi-asserted-by":"publisher","key":"e_1_2_10_13_1","DOI":"10.1038\/ejcn.2008.68"},{"doi-asserted-by":"publisher","key":"e_1_2_10_14_1","DOI":"10.1017\/S0007114511000067"},{"doi-asserted-by":"publisher","key":"e_1_2_10_15_1","DOI":"10.1186\/1475-2891-12-75"},{"doi-asserted-by":"publisher","key":"e_1_2_10_16_1","DOI":"10.1016\/j.juro.2013.07.102"},{"doi-asserted-by":"publisher","key":"e_1_2_10_17_1","DOI":"10.1016\/j.ajcnut.2022.12.022"},{"doi-asserted-by":"publisher","key":"e_1_2_10_18_1","DOI":"10.1016\/j.eururo.2019.08.016"},{"doi-asserted-by":"publisher","key":"e_1_2_10_19_1","DOI":"10.1016\/j.eururo.2014.02.034"},{"doi-asserted-by":"publisher","key":"e_1_2_10_20_1","DOI":"10.1093\/ije\/dyaa213"},{"key":"e_1_2_10_21_1","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019","volume":"45","author":"Textor J","year":"2017","journal-title":"Int J Epidemiol"},{"doi-asserted-by":"publisher","key":"e_1_2_10_22_1","DOI":"10.3233\/BLC-200006"},{"doi-asserted-by":"publisher","key":"e_1_2_10_23_1","DOI":"10.1091\/mbc.E19-02-0115"},{"unstructured":"Nederlandse Vereniging voor Urologie (EN: \u201cDutch Association of Urology\u201d). Alles over urologie. Niet\u2010spierinvasieve blaaskanker. Available at:https:\/\/www.allesoverurologie.nl\/zorgpaden\/niet\u2010spierinvasieve\u2010blaaskanker\/. Accessed July 2024","key":"e_1_2_10_24_1"},{"doi-asserted-by":"publisher","key":"e_1_2_10_25_1","DOI":"10.1038\/ejcn.2013.93"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.16665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:55:20Z","timestamp":1761724520000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.16665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1111\/bju.16665"],"URL":"https:\/\/doi.org\/10.1111\/bju.16665","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"2025-01-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}